Home > An overview of cannabis potency in Europe.

King, Leslie A (2004) An overview of cannabis potency in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[img]
Preview
PDF (EMCDDA Insights Series no.6) - Published Version
290kB

Cannabis is the illegal substance most commonly used in all countries of the European Union. The increased use of cannabis during the past decade has increased the profile of the drug. Used mainly by young adults, but also by many schoolchildren, cannabis is a drug consumed by individuals during their formative years, at a time when they may be more vulnerable to the long-term harmful effects of drug use. Comments in the media and elsewhere of a large increase in the potency of cannabis have raised concerns that the drug now available is much stronger than that available in the past.

To establish a scientific basis on which to advise policymakers and practitioners in the drugs field, the EMCDDA commissioned an investigation into cannabis potency in Europe. The results of this study are presented here.

Table of contents
• Analytical aspects
• Trends in cannabis potency in Europe
• The cannabis market in Europe: potency consideration
• Trends in cannabis potency in other countries
• Identification of information gaps, priorities for future research and recommendations


Item Type
Report
Publication Type
International, Report
Drug Type
Cannabis
Intervention Type
Harm reduction
Date
2004
Call No
REF, EMCDDA
Pages
71 p.
Publisher
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Lisbon
ISBN
92-9168-184-9
Edition
EMCDDA Insights Series no. 6
Notes
Includes bibliographical references, glossary of terms
EndNote
Accession Number
HRB 2568 (Available), HRB 2566 (Available)
Related (external) link

Repository Staff Only: item control page